© 2025 swii.ch health

Rare Insights

Exploring the ideas, innovations, and individuals shaping the future of rare disease.

EU JCA 2025 Explained: What Rare Disease Sponsors Need to Know Now

October 14, 2025 | 11:17 am

The EU Joint Clinical Assessment (JCA) is one of the most significant changes to hit market access in years.[…]

Read more

RAREready™ – AI-powered EU JCA & HTA readiness

© 2025 swii.ch health.

Privacy Policy
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept